CHIESI FARMACEUTICI S.P.A.
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1935-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.chiesigroup.com
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
- Conditions
- Interventions
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 40
- Registration Number
- NCT01651637
- Locations
- 🇬🇧
Liverpool Women's Hospital Neonatal Unit Liverpool Women's Hospital, Liverpool, United Kingdom
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase
- Conditions
- Interventions
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 51
- Registration Number
- NCT01602393
- Locations
- 🇺🇸
Memory Enhancement Center of NJ, Inc., Toms River, New Jersey, United States
🇺🇸Senior Adults Specialty Research, Austin, Texas, United States
🇮🇹Osp. Niguarda Ca'Granda, Dip. Di Neuroscienze, Milano, Italy
Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD
- Conditions
- Interventions
- First Posted Date
- 2012-04-25
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 191
- Registration Number
- NCT01584505
- Locations
- 🇧🇬
Hospital "Lozenets", Sofia, Bulgaria
🇭🇺Fővárosi Önkormányzat Szent János Kórháza és Észak-budai Egyesített Kórházai Tüdőgondozó Szakrendelő, Budapest, Hungary
🇬🇧Medicines Evaluation Unit, Langley Building, Manchester, United Kingdom
Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
- First Posted Date
- 2012-04-25
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 59
- Registration Number
- NCT01584492
- Locations
- 🇺🇦
Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine
🇵🇱Poradnia Alergologiczna, Debica, Debica, Poland, Poland
Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients
- First Posted Date
- 2012-04-13
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 542
- Registration Number
- NCT01577082
- Locations
- 🇮🇹
Cardio-Thoracic and Vascular Dept, University of Pisa, Pisa, Italy
Prevalence and Reversibility of Lung Hyperinflation in Asthma
- Conditions
- First Posted Date
- 2012-04-09
- Last Posted Date
- 2012-04-09
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 450
- Registration Number
- NCT01573364
- Locations
- 🇫🇷
Laboratoire Chiesi S.A., Courbevoie, France
A Study in Patients With Asthma
- Conditions
- Interventions
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 108
- Registration Number
- NCT01570478
- Locations
- 🇮🇹
Dipartimento Cardio-Polmonare - Azienda Ospedaliero-Universitaria - Padiglione Rasori, Parma, Italy
International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)
- Conditions
- First Posted Date
- 2012-03-30
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 8111
- Registration Number
- NCT01567280
- Locations
- 🇮🇹
Azienda Sanitaria Firenze Piero Palagi, Firenze, Italy
Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate
- Conditions
- Interventions
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 281
- Registration Number
- NCT01476813
- Locations
- 🇬🇧
Medicines Evaluation Unit Ltd., Manchester, United Kingdom
Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
- Conditions
- Interventions
- First Posted Date
- 2011-11-21
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 638
- Registration Number
- NCT01475032
- Locations
- 🇺🇦
Institute of Pediatrics, Kyiv, Ukraine
🇷🇴Spitalul Clinic Universitar de Urgenta Elias, Bucuresti, Romania
🇷🇺Moscow State Medical University, Moscow, Russian Federation